Overview

Intravenous Lidocaine for Fibromyalgia

Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
The effect of intravenous lidocaine infusion on manifestations of fibromyalgia manifestations were recorded before and 4 weeks after treatment. Pain intensity was rated on a numerical scale.The combination of 240 mg intravenous lidocaine (once a week) and 25 mg amitriptyline for 4 weeks did not modify pain intensity or manifestations in patients with fibromyalgia.
Phase:
N/A
Details
Lead Sponsor:
Federal University of São Paulo
Treatments:
Lidocaine